Literature summary for 3.1.26.13 extracted from

Fuji, H.; Urano, E.; Futahashi, Y.; Hamatake, M.; Tatsumi, J.; Hoshino, T.; Morikawa, Y.; Yamamoto, N.; Komano, J.
Derivatives of 5-nitrofuran-2-carboxylic acid carbamoyl methyl ester inhibit RNase H activity associated with HIV-1 reverse transcriptase (2009), J. Med. Chem., 52, 1380-1387.

Search for more literature for 3.1.26.13

Crystallization (Commentary)

Crystallization (Comment)	Organism
docking simulation studies. Residue His 539 and two metal ions in the RNase H catalytic center are involved in inhibition by compounds 5-nitrofuran-2-carboxylic acid adamantan-1-carbamoyl methyl ester and 5-nitrofuran-2-carboxylic acid [[4-(4-bromophenyl)-thiazol-2-yl]-(tetrahydrofuran-2-ylmethyl)-carbamoyl]-methyl ester	Human immunodeficiency virus 1

Inhibitors

Inhibitors	Comment	Organism	Structure
5-nitrofuran-2-carboxylic acid adamantan-1-carbamoyl methyl ester	inhibitor has little effect on bacterial RNase H activity in vitro	Human immunodeficiency virus 1
5-nitrofuran-2-carboxylic acid adamantan-1-carbamoyl methyl ester	-	Moloney murine leukemia virus
5-nitrofuran-2-carboxylic acid [[4-(4-bromophenyl)-thiazol-2-yl]-(tetrahydrofuran-2-ylmethyl)-carbamoyl]-methyl ester	additionally inhibits HIV-1 replication effectively. Inhibitor has little effect on bacterial RNase H activity in vitro	Human immunodeficiency virus 1
5-nitrofuran-2-carboxylic acid [[4-(4-bromophenyl)-thiazol-2-yl]-(tetrahydrofuran-2-ylmethyl)-carbamoyl]-methyl ester	-	Moloney murine leukemia virus

Organism

Organism	UniProt	Comment	Textmining
Human immunodeficiency virus 1	-	derived from clade B	-
Human immunodeficiency virus 1	-	derived from clade C	-
Human immunodeficiency virus 1	-	derived from CRF01 A_E	-
Moloney murine leukemia virus	-	-	-

IC50 Value

IC50 Value	IC50 Value Maximum	Comment	Organism	Inhibitor	Structure
0.0026	-	-	Human immunodeficiency virus 1	5-nitrofuran-2-carboxylic acid [[4-(4-bromophenyl)-thiazol-2-yl]-(tetrahydrofuran-2-ylmethyl)-carbamoyl]-methyl ester
0.0038	-	-	Human immunodeficiency virus 1	5-nitrofuran-2-carboxylic acid adamantan-1-carbamoyl methyl ester
0.0084	-	-	Moloney murine leukemia virus	5-nitrofuran-2-carboxylic acid adamantan-1-carbamoyl methyl ester
0.0086	-	-	Moloney murine leukemia virus	5-nitrofuran-2-carboxylic acid [[4-(4-bromophenyl)-thiazol-2-yl]-(tetrahydrofuran-2-ylmethyl)-carbamoyl]-methyl ester
0.0265	-	-	Human immunodeficiency virus 1	5-nitrofuran-2-carboxylic acid adamantan-1-carbamoyl methyl ester
0.0267	-	-	Human immunodeficiency virus 1	5-nitrofuran-2-carboxylic acid [[4-(4-bromophenyl)-thiazol-2-yl]-(tetrahydrofuran-2-ylmethyl)-carbamoyl]-methyl ester
0.0296	-	-	Human immunodeficiency virus 1	5-nitrofuran-2-carboxylic acid adamantan-1-carbamoyl methyl ester
0.0322	-	-	Human immunodeficiency virus 1	5-nitrofuran-2-carboxylic acid [[4-(4-bromophenyl)-thiazol-2-yl]-(tetrahydrofuran-2-ylmethyl)-carbamoyl]-methyl ester

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)